WO2001036367A2 - Organic compounds - Google Patents

Organic compounds Download PDF

Info

Publication number
WO2001036367A2
WO2001036367A2 PCT/EP2000/011471 EP0011471W WO0136367A2 WO 2001036367 A2 WO2001036367 A2 WO 2001036367A2 EP 0011471 W EP0011471 W EP 0011471W WO 0136367 A2 WO0136367 A2 WO 0136367A2
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
phenyl
hydrogen
alkyl
Prior art date
Application number
PCT/EP2000/011471
Other languages
French (fr)
Other versions
WO2001036367A3 (en
Inventor
Pierre Ducray
Jacques Bouvier
Ronald Kaminsky
Olivier Froelich
Original Assignee
Novartis Ag
Novartis-Erfindungen Verwaltungsgesellschaft M.B.H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis-Erfindungen Verwaltungsgesellschaft M.B.H filed Critical Novartis Ag
Priority to AU25068/01A priority Critical patent/AU2506801A/en
Publication of WO2001036367A2 publication Critical patent/WO2001036367A2/en
Publication of WO2001036367A3 publication Critical patent/WO2001036367A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids

Definitions

  • the present invention relates to the preparation of new compounds of formula I below that are suitable for controlling ectoparasites on domestic animals, productive livestock and pets. It relates to the preparation of those compounds and to their use in parasite control, and also to ectoparasiticidal compositions for use on domestic animals, productive livestock and pets, the compositions comprising at least one such compound as active ingredient, and to the use of such substances in the preparation of the said compositions.
  • X is hydrogen, halogen, phenyl or C ⁇ . 4 alkyl
  • Y is fluorine or chlorine
  • A is -O-, -S- or -N(R 1 )-, wherein F is C ⁇ . alkyl, phenylthio or tolylthio n is from 1 to 12; m is from 2 to 6;
  • R is hydrogen or one of the groups
  • Het is a saturated or unsaturated, 3- to 7-membered heterocyclic ring that optionally additionally comprises O or S as further hetero atom or the hetero group -N(C ⁇ -6 alkyl)-;
  • Aryl is phenyl or naphthyl; and R , R 3 , R 4 , R 5 , R 6 , R. and R 8 are each independently of the others hydrogen, C ⁇ . alkyl, C ⁇ - alkoxy, C 1-4 alkylthio, C ⁇ . 4 haloalkyl, C 2-6 alkenyl, C 2 .
  • a heterocyclic ring in the context of R is an aliphatic or aromatic cyclic radical comprising at least one oxygen, sulfur or nitrogen atom.
  • halogen in that case being fluorine, chlorine or bromine, but especially chlorine.
  • heterocycles special preference is given to pyridine, thiazole, tetrahydrofuran and tetrahydropyran, especially tetrahydropyran.
  • the number of substituents in the heterocycles cannot, of course, exceed the number of possible substitutions. For example, an oxirane radical bonded by way of carbon can naturally have only one substituent.
  • Alkyl on its own or as a constituent of a haloalkyl, alkoxy or haloalkoxy radical is to be understood as meaning a saturated, unbranched or branched hydrocarbon radical having from one to four carbon atoms, for example a substituent such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl or tert-butyl.
  • halo indicates that the substituent in question is partially or completely halogenated.
  • haloalkyl - as a group perse or as a structural element of other groups and compounds, such as of haloalkoxy, - are methyl substituted from one to three times by fluorine, chlorine and/or bromine, such as CHF 2 or CF 3 ; ethyl substituted from one to five times by fluorine, chlorine and/or bromine, such as CH 2 CF 3 , CF 2 CF 3 , CF 2 CCI 3 , CF 2 CHCI 2 , CF 2 CHF 2 , CF 2 CFCI 2 , CF 2 CHB.
  • halo and halogen denote halogen atoms and are generally fluorine, chlorine, bromine or iodine, especially fluorine or chlorine; as a substituent of an alkyl group they denote especially fluorine, and as a substituent of a phenyl ring they denote especially chlorine.
  • Alkenyl - as a group perse or as a structural element of other groups and compounds, such as of alkenyloxy, haloalkenyl or haloalkenyloxy - is, in each case giving due consideration to the number of carbon atoms contained in the group or compound in question, either straight-chained, e.g. vinyl, 1 -methylvinyl, allyl, 1-butenyl or 2-hexenyl, or branched, e.g. iso- propenyl.
  • Alkynyl is, in each case giving due consideration to the number of carbon atoms contained in the group in question, either straight-chained, e.g. propargyl, 2-butynyl or 5-hexynyl, or branched, e.g. 2-ethynylpropyl or 2-propargylisopropyl.
  • Aryl itself or as a moiety of a substituent is phenyl or naphthyl, especially phenyl, with aryl as a moiety of a substituent being either unsubstituted or mono- or poly- substituted by C ⁇ - 4 alkyl, C ⁇ . haloalkyl, C ⁇ - 4 alkoxy, d. haloalkoxy, halogen, cyano, hydroxy, amino or by nitro, wherein each poly-substitution is not limited to identical substituents, it being possible rather for there to be a mixture of substituents present.
  • a preferred group of compounds in the context of formula I is formed by those compounds wherein X is hydrogen, halogen or methyl; Y is fluorine or chlorine; A is -O-, n is from 1 to 6;
  • Another especially preferred group of compounds in the context of formula I is formed by the compounds wherein X is hydrogen, halogen or C 1-4 alkyl; Y is fluorine or chlorine; A is -O-; n is from 1 to 6; m is from 2 to 4;
  • R is the group 3 , w ere n et s ox rane, aziridine, 2H-azepine, dioxolane, pyrrolidine, piperidine, morpholine, pyridine, pyrrole, furan, thiene, imidazole, tetrahydrofuran, tetrahydropyran, dihydrofuran, dihydropyran, isoxazole, oxazole, thiazole, oxazoline, oxazolidine, imidazoline, imidazolidine or dioxane; and R 2 and R 3 are each independently of the other hydrogen, halogen, hydroxy, cyano, nitro, phenyl, amino, C ⁇ .
  • the present invention relates also to the preparation of compounds of formula I, which is carried out by reacting a compound of formula II
  • X, Y and n are as defined for formula I and Q is hydroxy or halogen, preferably chlorine or bromine, in the presence or absence of an inert solvent or solvent mixture, with a compound of formula III
  • R, A and m are as defined for formula I; the reaction preferably being carried out in the presence of a hydrophilic agent or of a catalyst when Q is hydroxy, and preferably being carried out in the presence of an acid-binding agent when Q is halogen.
  • reaction of II wherein Q is halogen with a compound of formula III is preferably carried out in an inert, hydroxyl-group-free solvent in the presence of an organic base, for example pyridine, 4-dimethylaminopyridine, lutidine, collidine, trialkylamine or N,N-dialkylaniline, or of a bicyclic, non-nucleophilic base, such as 1 ,4-diazabicyclo[2.2.2]octane (DABCO), 1 ,5- diazabicyclo[4.3.0]non-5-ene (DBN) or 1 ,8-diazabicyclo[5.4.0]undec-7-ene (1 ,5-5) (DBU).
  • an organic base for example pyridine, 4-dimethylaminopyridine, lutidine, collidine, trialkylamine or N,N-dialkylaniline, or of a bicyclic, non-nucleophilic base, such as 1 ,4-d
  • the reaction is generally carried out at temperatures of from -30°C to +70°C, preferably from -10°C to + 50°C.
  • Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloro- ethylene; ethers and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, etc.), anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethylenes, benzene, toluene, xylenes, petroleum ether
  • reaction of II wherein Q is hydroxy with a compound of formula III is advantageously carried out in the presence of water-removing reagents customary for esterification, for example in the presence of a carbodiimide [dicyclohexylcarbodiimide (DCC)] or of a 1 -alkyl- 2-halopyridinium salt, such as 1 -methyl-2-chloropyridinium iodide.
  • DCC dicyclohexylcarbodiimide
  • a 1 -alkyl- 2-halopyridinium salt such as 1 -methyl-2-chloropyridinium iodide.
  • the reaction is in that case advantageously carried out at temperatures of from -30°C to +70°C, preferably from -10°C to +50°C, in the presence of a solvent or solvent mixture that is inert to the reaction.
  • the reaction is preferably carried out in the presence of a base, for example in the presence of an organic amine, such as a trialkylamine (trimethylamine, triethylamine, tripropylamine or diisopropylethylamine), a pyridine (pyridine itself, 4-dimethylaminopyridine or 4-pyrrolidino-pyridine), a morpholine (N-methylmorpholine) or an N,N-dialkylaniline (N,N- dimethylaniline or N-methyl-N-ethylaniline).
  • an organic amine such as a trialkylamine (trimethylamine, triethylamine, tripropylamine or diisopropylethylamine), a pyridine (pyridine itself, 4-dimethylaminopyridine or 4-pyrrolidino-pyridine), a morpholine (N-methylmorpholine) or an N,N-dialkylaniline (N,N- dimethylaniline or N-methyl-N
  • Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloroethylene; ethers and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, - 6 -
  • anisole, dioxane and tetrahydrofuran anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethyl acetate (acetic acid ethyl ester), propyl acetate and butyl acetate; and mixtures of such solvents with one another.
  • the conversion of free compounds I into salts and of salts into free compounds I or into other salts is effected in customary manner, e.g. by treatment of a free compound I with an acid, or of a salt with a base.
  • ectoparasites are understood to mean in particular insects, mites and ticks. Included are insects of the following orders: Lepidoptera, Coleoptera, Homoptera, Heteroptera, Diptera, Thysanoptera, Orthoptera, Psoroptes, Anoplura, Siphonaptera, Mallophaga, Thysanura, Isoptera, Psocoptera and Hymenoptera.
  • ectoparasites that trouble humans and animals and transmit pathogens
  • pathogens for example flies, such as Musca domestica, Musca vetustissima, Musca autumnalis, Fannia canicularis, Sarcophaga camaria, Lucilia cuprina, Hypoderma bovis, Hypoderma lineatum, Chrysomyia chloropyga, Dermatobia hominis, Cochliomyia hominivorax, Gasterophilus intestinalis, Oestrus ovis, Stomoxys calcitrans, Haematobia irritans and midges (Nematocera), such as Culicidae, Simuliidae, Psychodidae, and also bloodsucking parasites, for example fleas, such as Ctenocephalides felis and Ctenocephalides canis (cat and dog fleas), Xenopsylla cheopis, Pulex irritans, Dermatophilus pen
  • ticks are, for example, Boophilus, Amblyomma, Anocentor, Dermacentor, Haemaphysalis, Hyalomma, Ixodes, Rhipicentor, Margaropus, Rhipicephalus, Argas, Otobius and Ornithodoros and the like that preferentially infest warm-blooded animals, including farm animals, such as cows, pigs, sheep and goats, poultry, such as hens, turkeys and geese, animals bred for their fur, such as mink, fox, chinchillas, rabbits and the like, and domestic animals, such as cats and dogs, but also humans.
  • farm animals such as cows, pigs, sheep and goats
  • poultry such as hens, turkeys and geese
  • animals bred for their fur such as mink, fox, chinchillas, rabbits and the like
  • domestic animals such as cats and dogs, but also humans.
  • Ticks may be subdivided into hard and soft ticks and are characterised by the fact that they infest one, two or three host animals. They attach themselves to a suitable host animal and suck blood or body fluid. Fully replete female ticks fall off the host animal and lay large amounts of eggs (2000 to 3000) in a suitable niche in the ground or in any other protected site, where the larvae hatch out. These in turn look for a host animal from which to suck blood. Larvae of ticks that infest only one host animal moult twice and in so doing become nymphs and finally adult ticks without leaving the host animal initially selected. Larvae of ticks that infest two or three host animals fall off after the blood meal, moult in the surrounding area and, as nymphs or adult ticks, look for a second or third host on which to suck.
  • Ticks are responsible worldwide for carrying and transmitting many human and animal diseases.
  • the most significant ticks owing to their economic effect, are Boophilus, Rhipicephalus, Ixodes, Hyalomma, Amblyomma and Dermacentor. They are carriers of bacterial, viral, rickettsial and protozoal diseases and cause tick paralysis and tick toxicosis. Just a single tick can cause paralysis as a result of its saliva penetrating the host animal as the tick takes its nourishment. Diseases triggered by ticks are usually carried by ticks that infest a plurality of host animals.
  • ticks are responsible for the death of, or injury to, a large number of domestic and farm animals worldwide.
  • ixodid ticks transmit the agent of chronically damaging Lyme disease from wild animals to humans.
  • ticks are responsible for large-scale economic loss in livestock production. The losses are attributable not only to the death of the host animals but also to damage to the coat, growth loss, reduction in milk production and the reduced value of the meat.
  • fleas are not only a nuisance but are also disease carriers, which, especially in moist-warm climatic regions, for example in the Mediterranean region, the southern part of the USA, etc., transmit various fungal diseases from host animal to host animal and to the animal keeper. Especially at risk are people having a weakened immune system or children whose immune system has not yet fully developed.
  • the present invention accordingly preferably relates to a method of controlling parasites on domestic animals, productive livestock and pets, which method comprises administering an effective amount of a composition that comprises at least one compound of formula I or a physiologically tolerable salt thereof, preferably topically, to an infested warm-blooded animal for curative treatment or to a parasite-free warm-blooded animal for preventative treatment.
  • a composition that comprises at least one compound of formula I or a physiologically tolerable salt thereof, preferably topically, to an infested warm-blooded animal for curative treatment or to a parasite-free warm-blooded animal for preventative treatment.
  • Pour-on and spot-on formulations are especially preferred forms of topical administration, but administration in the form of sprays, ointments, solutions, baths or powders may also be expedient.
  • the compound of formula I according to the invention will normally be administered not in pure form but preferably in the form of a composition that comprises, in addition to the active ingredient, constituents that assist administration, suitable constituents being those which are tolerated by the host animal.
  • the control according to the invention covers both the adult parasites and the juvenile stages of the parasites. Further active substances may of course be added to such compositions in order to broaden the spectrum of activity of the active ingredient.
  • compositions to be administered in accordance with the invention generally comprise from 0.1 to 99% by weight, especially from 0.1 to 95% by weight, of a compound of formula I according to the invention and from 99.9 to 1% by weight, especially from 99.9 to 5% by weight, of a solid or liquid, physiologically tolerable carrier, including from 0 to 25% by weight, especially from 0.1 to 25% by weight, of a non-toxic dispersant.
  • a solid or liquid, physiologically tolerable carrier including from 0 to 25% by weight, especially from 0.1 to 25% by weight, of a non-toxic dispersant.
  • compositions may comprise further additives, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as other active ingredients for obtaining special effects.
  • additives such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as other active ingredients for obtaining special effects.
  • physiologically tolerable carriers known from veterinary medicinal practice for oral, percutaneous and topical administration can be used as formulation auxiliaries. Some examples are given below.
  • Suitable carriers are especially fillers, such as sugars, for example lactose, saccharose, mannitol or sorbitol, cellulose preparations and/or calcium phosphates, for example tricalcium phosphate or calcium hydrogen phosphate, and binders, such as starch pastes using, for example, maize, wheat, rice or potato starch, gelatins, tragacanth, methyl cellulose and/or, if desired, disintegrators, such as the above-mentioned starches, also carboxymethyl starch, crosslinked polyvinylpyrrolidone, agar, alginic acid or a salt thereof, such as sodium alginate.
  • fillers such as sugars, for example lactose, saccharose, mannitol or sorbitol, cellulose preparations and/or calcium phosphates, for example tricalcium phosphate or calcium hydrogen phosphate
  • binders such as starch pastes using, for example, maize, wheat, rice or potato star
  • Adjuvants are especially flow regulators and lubricants, for example silicic acid, talc, stearic acid or salts thereof, such as magnesium or calcium stearate, and/or polyethylene glycol.
  • Dragee cores can be provided with suitable, optionally enteric, coatings, there being used, inter alia, concentrated sugar solutions which may comprise gum arabic, talc, polyvinylpyrrolidone, polyethylene glycol and/or titanium dioxide, or coating solutions in suitable organic solvents or solvent mixtures or, for the preparation of enteric coatings, solutions of suitable cellulose preparations, such as acetyl cellulose phthalate or hydroxypropylmethylcellulose phthalate. Dyes, flavourings or pigments may be added to the tablets or dragee coatings, for example for identification purposes or to indicate different doses of active ingredient.
  • the preferred pour-on or spot-on method comprises applying the compound of formula I to a locally defined area of the skin or coat, advantageously on the back of the neck or the backbone of the animal. This is carried out, for example, by applying a swab or squirt of the pour-on or spot-on formulation to a relatively small area of the coat from where the active ingredient becomes distributed over a wide area of the coat almost automatically, as a result of the spreading constituents of the formulation and assisted by the movements of the animal.
  • Pour-on and spot-on formulations advantageously comprise carriers that promote rapid distribution over the surface of the skin or in the coat of the host animal and are generally termed spreading oils.
  • suitable oils for example, oily solutions; alcoholic and isopropanolic solutions, e.g.
  • solutions of 2-octyldodecanol or oleyl alcohol solutions in esters of monocarboxylic acids, such as isopropyl myristate, isopropyl palmitate, lauric acid oxalic ester, oleic acid oleyl ester, oleic acid decyl ester, hexyl laurate, oleyl oleate, decyl oleate, capric acid esters of saturated fatty alcohols of chain length C ⁇ 2 -C 18 ; solutions of esters of dicarboxylic acids, such as dibutyl phthalate, diisopropyl isophthalate, adipic acid diisopropyl ester, di-n-butyl adipate or solutions of esters of aliphatic acids, e.g.
  • glycols may be advantageous for a dispersant known from the pharmaceutical or cosmetic industry also to be present.
  • examples are pyrrolidin-2-one, N-alkylpyrrolidin-2-one, acetone, polyethylene glycol and its ethers and esters, propylene glycol and synthetic triglycerides.
  • Th e oily solutions include e.g. vegetable oils, such as olive oil, groundnut oil, sesame oil, pine oil, linseed oil and castor oil. The vegetable oils may also be in epoxidised form. It is also possible to use paraffins and silicone oils.
  • a pour-on or spot-on formulation will contain from 1 to 20% by weight of a compound of formula (I), from 0.1 to 50% by weight of dispersant and from 45 to 98.9% by weight of solvent.
  • the pour-on or spot-on method can be used especially advantageously for herd animals, such as cattle, horses, sheep and pigs, where it is difficult or time-consuming to treat all the animals orally or via injection.
  • this method can of course also be used for all other animals, including individual domestic animals and pets, and is very popular with the keepers of animals because it can often be carried out without the expert assistance of a veterinary surgeon.
  • Dustable powders 25 parts by weight compound of formula I 1 part by weight sodium lauryl sulfate, 3 parts by weight colloidal silica gel, and 71 parts by weight urea.
  • Suspension concentrates compound of formula I : from 5 to 75 %, preferably from 10 to 50 % water: from 94 to 24 %, preferably from 88 to 30 % surfactant: from 1 to 40 %, preferably from 2 to 30 %
  • compositions may also comprise further additives, such as stabilisers, e.g. vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rape oil or soybean oil), antifoams, e.g. silicone oil, preservatives, viscosity regulators, binders and tackifiers, as well as fertilisers, or other active ingredients for obtaining special effects.
  • stabilisers e.g. vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rape oil or soybean oil)
  • antifoams e.g. silicone oil
  • preservatives e.g. silicone oil
  • viscosity regulators e.g. binders and tackifiers
  • fertilisers e.g., binders and tackifiers
  • the compounds of formula I according to the invention can be used alone or in combination with other biocides.
  • biocides for example, in order to enhance their effect they can be combined with pesticides having the same direction of action or in order to broaden the spectrum of activity they can be combined with substances having a different direction of action. It may also be advantageous to add repellents.
  • the compounds of formula I are advantageously combined with substances having endoparasiticidal properties. They can, of course, also be used in combination with anti-bacterial compositions.
  • the compounds of formula I are "adulticides", that is to say they are effective especially against the fully grown stages of the target parasites, it can be highly advantageous to add pesticides that attack the juvenile stages of the parasite as well. In that manner most of the parasites causing substantial economic damage are targeted. This also helps considerably in avoiding the development of resistance. Some combinations can also produce synergistic effects, which means that the total amount of active substance used can be reduced, which is desirable from the ecological standpoint. Preferred groups of combination partners and especially preferred combination partners are mentioned hereinbelow, it being possible for combinations to comprise, in addition to a compound of formula I, one or more such partners.
  • Suitable mixing partners are biocides, such as the insecticides and acaricides mentioned hereinbelow that are sufficiently well known to the person skilled in the art and that have various action mechanisms, e.g. chitin synthesis inhibitors, growth regulators; active ingredients that act like juvenile hormones; active ingredients that act as adulticides; broad- spectrum insecticides, broad-spectrum acaricides and nematicides; and also the sufficiently well known anthelmintics and substances that repel insects and/or acarina, so-called repellents and detachers.
  • suitable insecticides and acaricides are:
  • LV a preparation comprising insect-active fungi
  • LVI a preparation comprising insect-active viruses
  • Non-limiting examples of suitable repelling substances are:
  • XXXVI S-tert-butylthiomethyl 0,0-dimethyl phosphorodithioate (terbufos), from The Pesticide Manual, 1 1 ⁇ Ed. (1997), The British Crop Protection Council, London, page 1165;
  • XXXVII ethyl (3-fert-butyl-1-dimethylcarbamoyl-1 H-1 ,2,4-triazol-5-yl-thio)-acetate, (triazamate), from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 1224;
  • Pesticide Manual 11 th Ed. (1997), The British Crop Protection Council, London, page 507;
  • XLVII 4-phenoxyphenyl (f?S)-2-(pyridyloxy)propyl ether (pyriproxyfen), from The Pesticide
  • (LIN) a preparation comprising insect-active nematodes, preferably Heterorhabditis bacteriophora and Heterorhabditis megidis, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 671 ; Steinernema feltiae, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 1115, and Steinernema scapterisci, from The Pesticide Manual, 11 ,h Ed. (1997), The British Crop Protection Council, London, page 1116;
  • LV a preparation comprising insect-active fungi, preferably Verlicillium lecanii, from The Pesticide Manual, 1 1 , Ed. (1997), The British Crop Protection Council, London, page 1266; Beauveria brogniartii, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 85; and Beauveria bassiana, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 83;
  • LPI a preparation comprising insect-active viruses, preferably Neodipridon Sertifer NPV, from The Pesticide Manual, 11 th Ed. (1997), The British Crop Protection Council, London, page 1342; Mamestra brassicae NPV, from The Pesticide Manual, 11 Ed. (1997), The British Crop Protection Council, London, page 759; and Cydia pomonella granulosis virus, from The Pesticide Manual, 1 1 th Ed. (1997), The British Crop Protection Council,
  • Crop Protection Council London, page 1094; and (CLXXXIII) ( ⁇ /'-[4-methoxy-biphenyl-3-yl]-hydrazinecarboxylic acid isopropyl ester (D 2341), from the Brighton Crop Protection Conference, 1996, 487- 493; (R2) Book of Abstracts, 212th ACS National Meeting Orlando, FL, August 25-29 (1996),
  • a further substantial aspect of the present invention relates to combination preparations for the control of parasites in or on warm-blooded animals, which combination preparations comprise, in addition to a compound of formula I, at least one further active ingredient having the same direction of action or a different direction of action and at least one physiologically tolerable carrier.
  • the present invention is not limited to combinations of two constituents.
  • erythrocytes aspartate aminotransferase (ASAT) haemoglobin (HB) alanine aminotransferase (ALAT) mean cell volume (HCT) creatine kinase (CK/NAC) mean cell-haemoglobin (MCH) ⁇ -glutamate transpeptidase (G-GT) mean cell-haemoglobin concentration total bilirubin (TBILI)
  • MCHC leucocytes
  • WBC creatinine
  • CREA blood platelets
  • PHT glucose
  • GLUC glucose
  • PHT glutamate dehydrogenase
  • BUN blood-urea-nitrogen
  • TOT. PROTEIN albumin
  • ALB globulin
  • GLOB globulin
  • NA sodium
  • K calcium
  • CA calcium
  • test substances do not at any time prove to cause local side- effects and the blood and chemical values measured show a range of variation absolutely identical to that for the untreated control animals.
  • the compounds of formula I e.g. compounds nos. 1.1-1.8, 1.39 and 2.1 , prove to be well tolerated up to a dose of 100 mg/kg under the test conditions.
  • Example 2 In vivo activity against mange mites on sheep after pour-on application Healthy sheep having an average body weight of approximately 35 kg are artificially infested, between the shoulder blades and in the groin area, with mange (Psoroptes ovis) of all stages of development. After 3 weeks, approximately 90% of the sheep have infested areas of skin of about 25 - 50 cm 2 . The infested sheep are selected for the remaining tests and, in order to be able to distinguish clearly between them, they are provided with numbered eartags. For the entire duration of the test, the sheep are kept in individual pens (0.9 x 1.2 m) having a slatted grid floor.
  • Example 3 In vivo action against mouse mites by topical treatment
  • mice infested with mites are anaesthetised and studied under a stereomicroscope to determine the density of the mite population.
  • the mice are divided into groups having the same index of infestation, that is to say each having the same mite population, the index consisting of a scale from 1 (no mites) to 30 (greatest mite density). For the purposes of the test, only mice that score at least 25 on the said scale (high mite density) are used.
  • the test substance is applied to the coat in the form of a solution, suspension or emulsion as a pour-on formulation, that is to say, topically.
  • the dose is in the range from 32 to 0.1 mg/kg of body weight.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

There are described new compounds of formula (I) wherein X is hydrogen, halogen, phenyl or C1-4alkyl; Y is fluorine or chlorine; A is -O-, -S- or -N(R1)-, wherein R1 is C1-4alkyl, phenylthio or tolylthio; n is from 1 to 12; m is from 2 to 6; R is hydrogen or one of groups (A) or (B) wherein Het is a saturated or unsaturated , 3- to 7-membered heterocyclic ring that optionally additionally comprises O or S as further hetero atom or the hetero group -N(C1-6alkyl)-; Aryl is phenyl or naphthyl; and R2, R3, R4, R5, R6, R7 and R8 are each independently of the others hydrogen, C1-4alkyl, C1-4alkoxy, C1-4alkylthio, C1-4haloalkyl, C2-6alkenyl, C2-6alkynyl, halogen, hydroxy, cyano, nitro, phenyl, amino, C1-4alkylamino, (C1-4alkyl)2amino, C1-4alkylsulfonyl or arylsulfonyl; in free form or in the form of physiologically tolerable salts. Also described are the preparation and use of such substances in the control of ectoparasites on domestic animals, productive livestock and pets, and ectoparasiticidal compositions for use on such animals.

Description

Organic compounds
The present invention relates to the preparation of new compounds of formula I below that are suitable for controlling ectoparasites on domestic animals, productive livestock and pets. It relates to the preparation of those compounds and to their use in parasite control, and also to ectoparasiticidal compositions for use on domestic animals, productive livestock and pets, the compositions comprising at least one such compound as active ingredient, and to the use of such substances in the preparation of the said compositions.
The substances according to the invention are compounds of formula I
Figure imgf000002_0001
wherein X is hydrogen, halogen, phenyl or Cι.4alkyl;
Y is fluorine or chlorine;
A is -O-, -S- or -N(R1)-, wherein F is Cι. alkyl, phenylthio or tolylthio n is from 1 to 12; m is from 2 to 6;
R is hydrogen or one of the groups
Figure imgf000002_0002
wherein Het is a saturated or unsaturated, 3- to 7-membered heterocyclic ring that optionally additionally comprises O or S as further hetero atom or the hetero group -N(Cι-6alkyl)-; Aryl is phenyl or naphthyl; and R , R3, R4, R5, R6, R. and R8 are each independently of the others hydrogen, Cι. alkyl, Cι- alkoxy, C1-4alkylthio, Cι.4haloalkyl, C2-6alkenyl, C2.6alkynyl, halogen, hydroxy, cyano, nitro, phenyl, amino, Cι-4alkylamino,
Figure imgf000002_0003
Cι- alkylsulfonyl or arylsulfonyl; in free form or in the form of physiologically tolerable salts.
A heterocyclic ring in the context of R is an aliphatic or aromatic cyclic radical comprising at least one oxygen, sulfur or nitrogen atom. Preference is given to five- and six-membered heterocycles, for example oxirane, aziridine, 2H-azepine, dioxolane, pyrrolidine, piperidine, morpholine, pyridine, pyrrole, furan, thiene, imidazole, tetrahydrofuran, tetrahydropyran, dihydrofuran, dihydropyran, isoxazole, oxazole, thiazole, oxazoline, oxazolidine, imidazoline, imidazolidine or dioxane. Preference is given especially to those that are unsubstituted or have one or two halogen atoms, halogen in that case being fluorine, chlorine or bromine, but especially chlorine. Of those heterocycles, special preference is given to pyridine, thiazole, tetrahydrofuran and tetrahydropyran, especially tetrahydropyran. The number of substituents in the heterocycles cannot, of course, exceed the number of possible substitutions. For example, an oxirane radical bonded by way of carbon can naturally have only one substituent.
Alkyl on its own or as a constituent of a haloalkyl, alkoxy or haloalkoxy radical is to be understood as meaning a saturated, unbranched or branched hydrocarbon radical having from one to four carbon atoms, for example a substituent such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl or tert-butyl. The prefix "halo" indicates that the substituent in question is partially or completely halogenated. Examples of haloalkyl - as a group perse or as a structural element of other groups and compounds, such as of haloalkoxy, - are methyl substituted from one to three times by fluorine, chlorine and/or bromine, such as CHF2 or CF3; ethyl substituted from one to five times by fluorine, chlorine and/or bromine, such as CH2CF3, CF2CF3, CF2CCI3, CF2CHCI2, CF2CHF2, CF2CFCI2, CF2CHB.2, CF2CHCIF, CF2CHBrF or CCIFCHCIF; propyl or isopropyl substituted from one to seven times by fluorine, chlorine and/or bromine, such as CH2CHBrCH2Br, CF2CHFCF3) CH2CF2CF3 or CH(CF3) 2, and butyl or an isomer thereof substituted from one to nine times by fluorine, chlorine and/or bromine, such as CF(CF3)CHFCF3 or CH2(CF2)2CF3. The terms "halo" and "halogen" denote halogen atoms and are generally fluorine, chlorine, bromine or iodine, especially fluorine or chlorine; as a substituent of an alkyl group they denote especially fluorine, and as a substituent of a phenyl ring they denote especially chlorine.
Alkenyl - as a group perse or as a structural element of other groups and compounds, such as of alkenyloxy, haloalkenyl or haloalkenyloxy - is, in each case giving due consideration to the number of carbon atoms contained in the group or compound in question, either straight-chained, e.g. vinyl, 1 -methylvinyl, allyl, 1-butenyl or 2-hexenyl, or branched, e.g. iso- propenyl. Alkynyl is, in each case giving due consideration to the number of carbon atoms contained in the group in question, either straight-chained, e.g. propargyl, 2-butynyl or 5-hexynyl, or branched, e.g. 2-ethynylpropyl or 2-propargylisopropyl.
Aryl itself or as a moiety of a substituent, e.g. arylsulfonyl, is phenyl or naphthyl, especially phenyl, with aryl as a moiety of a substituent being either unsubstituted or mono- or poly- substituted by Cι-4alkyl, Cι. haloalkyl, Cι-4alkoxy, d. haloalkoxy, halogen, cyano, hydroxy, amino or by nitro, wherein each poly-substitution is not limited to identical substituents, it being possible rather for there to be a mixture of substituents present.
A preferred group of compounds in the context of formula I is formed by those compounds wherein X is hydrogen, halogen or methyl; Y is fluorine or chlorine; A is -O-, n is from 1 to 6;
m is 2 or 3; R is
Figure imgf000004_0001
, wherein Aryl is phenyl; and R4l R5, R6, R7 and R8 are each independently of the others hydrogen, Cι.4alkyl, C1-4alkoxy, Cι.4alkylthio, d-4haloalkyl, halogen, hydroxy, cyano, nitro, phenyl, amino, Cι- alkylamino, (Cι-4alkyl)2amino, C1-4alkyl- sulfonyl or arylsulfonyl; in free form or in the form of physiologically tolerable salts, and, of those compounds, especially compounds wherein R , R5, R6, R7 and R8 are each independently of the others hydrogen, fluorine, chlorine, methyl, methoxy, trifluoromethyl, cyano or nitro.
Another especially preferred group of compounds in the context of formula I is formed by the compounds wherein X is hydrogen, halogen or C1-4alkyl; Y is fluorine or chlorine; A is -O-; n is from 1 to 6; m is from 2 to 4;
Figure imgf000004_0002
R is the group 3 , w ere n et s ox rane, aziridine, 2H-azepine, dioxolane, pyrrolidine, piperidine, morpholine, pyridine, pyrrole, furan, thiene, imidazole, tetrahydrofuran, tetrahydropyran, dihydrofuran, dihydropyran, isoxazole, oxazole, thiazole, oxazoline, oxazolidine, imidazoline, imidazolidine or dioxane; and R2 and R3 are each independently of the other hydrogen,
Figure imgf000004_0003
halogen, hydroxy, cyano, nitro, phenyl, amino, Cι. alkylamino, (Cι- a!kyl)2amino, d-4alkyl- sulfonyl or arylsulfonyl; in free form or in the form of physiologically tolerable salts; and, of those compounds, especially compounds wherein R2 and R3 are each independently of the other hydrogen, fluorine, chlorine, methyl, methoxy, trifiuoromethyl, cyano or nitro.
Special preference is given to each individual compound selected from the series: 2-hydroxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; 3-methylphenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; tetrahydropyranyl-2-oxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; 2-nitro-4-phenylphenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; 4-phenylphenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; phenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; 4-chlorophenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; 2,3,6-trifluorophenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; 4-bromophenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; 3-methylphenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester; and 4-methylphenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester.
The present invention relates also to the preparation of compounds of formula I, which is carried out by reacting a compound of formula II
Figure imgf000005_0001
wherein X, Y and n are as defined for formula I and Q is hydroxy or halogen, preferably chlorine or bromine, in the presence or absence of an inert solvent or solvent mixture, with a compound of formula III
(CH2)m R
wherein R, A and m are as defined for formula I; the reaction preferably being carried out in the presence of a hydrophilic agent or of a catalyst when Q is hydroxy, and preferably being carried out in the presence of an acid-binding agent when Q is halogen. The reaction of II wherein Q is halogen with a compound of formula III is preferably carried out in an inert, hydroxyl-group-free solvent in the presence of an organic base, for example pyridine, 4-dimethylaminopyridine, lutidine, collidine, trialkylamine or N,N-dialkylaniline, or of a bicyclic, non-nucleophilic base, such as 1 ,4-diazabicyclo[2.2.2]octane (DABCO), 1 ,5- diazabicyclo[4.3.0]non-5-ene (DBN) or 1 ,8-diazabicyclo[5.4.0]undec-7-ene (1 ,5-5) (DBU). The reaction is generally carried out at temperatures of from -30°C to +70°C, preferably from -10°C to + 50°C. The reaction is advantageously carried out in the presence of a solvent or solvent mixture that is inert to the reaction. Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloro- ethylene; ethers and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, etc.), anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethyl acetate (acetic acid ethyl ester), propyl acetate and butyl acetate; ketones, such as acetone, diethyl ketone and methyl ethyl ketone; and mixtures of such solvents with one another. The reaction is normally carried out at ambient pressure, but can also be carried out at elevated or reduced pressure.
The reaction of II wherein Q is hydroxy with a compound of formula III is advantageously carried out in the presence of water-removing reagents customary for esterification, for example in the presence of a carbodiimide [dicyclohexylcarbodiimide (DCC)] or of a 1 -alkyl- 2-halopyridinium salt, such as 1 -methyl-2-chloropyridinium iodide. The reaction is in that case advantageously carried out at temperatures of from -30°C to +70°C, preferably from -10°C to +50°C, in the presence of a solvent or solvent mixture that is inert to the reaction. The reaction is preferably carried out in the presence of a base, for example in the presence of an organic amine, such as a trialkylamine (trimethylamine, triethylamine, tripropylamine or diisopropylethylamine), a pyridine (pyridine itself, 4-dimethylaminopyridine or 4-pyrrolidino-pyridine), a morpholine (N-methylmorpholine) or an N,N-dialkylaniline (N,N- dimethylaniline or N-methyl-N-ethylaniline). Suitable solvents include, for example, aliphatic and aromatic hydrocarbons, such as benzene, toluene, xylenes, petroleum ether and hexane; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride and tetrachloroethylene; ethers and ether-type compounds, such as dialkyl ethers (diethyl ether, diisopropyl ether, tert-butyl methyl ether, - 6 -
etc), anisole, dioxane and tetrahydrofuran; nitriles, such as acetonitrile and propionitrile; esters, such as ethyl acetate (acetic acid ethyl ester), propyl acetate and butyl acetate; and mixtures of such solvents with one another.
The conversion of free compounds I into salts and of salts into free compounds I or into other salts is effected in customary manner, e.g. by treatment of a free compound I with an acid, or of a salt with a base.
Compounds of the type of formulae II and III and their preparation are known from the literature or they can be prepared analogously to known examples. Compounds III can also be prepared according to the processes described in US-4 950 666 and EP-A-0 432 861. It is also possible to work in accordance with the procedures described in EP-0 577 555, pages 5 - 8.
Preparation Examples
Example 1 : Preparation of 2-hvdroxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester
Figure imgf000007_0001
2 g of 5,5-difluoropent-4-enoic acid are introduced into 50 ml of methylene chloride, and 150 mg of dimethylaminopyridine and 1.3 ml of ethylene glycol are added, and the batch is cooled to 0°C. At a temperature of about from 0°C to + 5°C there are added in portions a total of 2.5 g of N,N'-dicyclohexylcarbodiimide, the ice-cooling is removed and the reaction mixture is allowed to warm to room temperature in the course of about 16 hours. The N,N'- dicyclohexylurea that precipitates out is separated off and discarded. The solvent is removed in vacuo and the residue is purified by column chromatography on silica gel (eluant: hexane/ethyl acetate, 2:1 ). The title substance is obtained in the form of an oil, nD 23 = 1.455.
Example 2: Preparation of 3-methylphenoxyethyl (4-methyl-5,5-difluoropent-4-enoic acid) ester
Figure imgf000007_0002
200 mg of 5,5-difluoropent-4-enoic acid chloride in 2 ml of dichloroethene are added in portions, at room temperature, to a mixture of 173 mg of 2-(3-methylphenoxy)ethanol, 1 g of an Amberlyst ion exchanger to take up the HCI that is produced, and 2 ml of dichloroethene. The mixture is stirred for 12 hours under normal pressure and at room temperature, and then 2 drops of water are added and the mixture is stirred further for about another 10 minutes. The ion exchanger is then filtered off and 1 g of Amberlyst ion exchanger is again added to the filtrate, and the batch is stirred further. After about 1 hour the ion exchanger is filtered off and the filtrate is concentrated in vacuo to yield a viscous oil, which is purified by chromatography on silica gel (1 :2 ethyl ether/n-hexane). After removal of the solvent, 200 mg of the title substance are obtained in the form of a colourless oil, nD 23 = 1.480.
Example 3: Preparation of 2-tetrahydropyranyl-2-oxyethyl (4-methyl-5,5-difluoropent-4- enoic acid) ester
Figure imgf000008_0001
1 g of 5,5-difluoropent-4-enoic acid chloride is added in portions, with ice-cooling, to a solution of 722 mg of 2-(2-tetrahydropyranyloxy)ethanol and 1 ml of pyridine in 60 ml of dichloroethene. The mixture is stirred for 12 hours under normal pressure and at room temperature. The mixture is then concentrated in vacuo and the residue is taken up in ethyl ether/2M HCI. The organic phase is separated off, then washed once with 2M HCI, twice with aqueous sodium hydrogen carbonate solution and once with sodium chloride solution, dried over sodium sulfate, filtered and concentrated in vacuo to yield 1.5 g of a viscous oil, which is purified by chromatography on silica gel (1 :2 ethyl ether/n-hexane). After removal of the solvent, 1.2 g of the title substance are obtained in the form of a colourless oil, nD 23 = 1.441.
The examples of formula I given below can be prepared in an analogous manner.
Figure imgf000009_0001
1.29 F C2H5 3 2 2,3,6-tri-F-phenyl
1.30 F C Hg-S 3 2 4-Br-phenyl
1.31 Cl C Hg-t 3 2 3-CH3-phenyl
1.32 F C2H5 3 2 4-CH3-phenyl
1.33 F CH3 3 2 naphth-1 -yl
1.34 F CH3 3 2 3-CI-naphth-1 -yl
1.35 F CH3 3 2 naphth-2-yl
1.36 F CH3 3 2 2-CH3-naphth-1-yl
1.37 Cl C2H5 3 2 naphth-1 -yl
1.38 F CH3 3 2 2,4-di-NO2-phenyl oil
1.39 F CH3 3 2 2,3,4,5, 6-penta-F-phenyl nD 23 = 1.431
1.40 F CH3 3 2 3,5-di-NO2-phenyl
1.41 F C2H5 3 2 3-CFg-phenyl
1.42 Cl CH3 3 2 2-NO2-phenyl
1.43 F CH3 3 2 2-NH2-phenyl
1.44 F CH3 2 2 2-NO2-4-(C6H5)phenyl
1.45 F CH3 2 2 4-(C6H5)phenyl
1.46 F CH3 2 2 phenyl
1.47 F CH3 2 2 4-CI-phenyl
1.48 F CH3 2 2 2,3,6-tri-F-phenyl
1.49 F CH3 4 2 4-Br-phenyl
1.50 F CH3 4 2 3-CH3-phenyl
1.51 F CH3 5 2 4-CH3-phenyl
1.52 Cl CH3 4 2 2-NO2-4-(C6H5)phenyl
1.53 Cl CH3 6 2 4-(C6H5)phenyl
1.54 Cl CH3 6 2 phenyl
1.55 Cl CH3 8 2 4-CI-phenyl
1.56 Cl CH3 9 2 2,3,6-tri-F-phenyl
1.57 Cl CH3 4 3 4-Br-phenyl
1.58 Cl CH3 3 3 3-CH3-phenyl
1.59 Cl CH3 3 3 4-CH3-phenyl
1.60 F H 3 3 2-NO2-4-(C6H5)phenyl
1.61 F H 5 3 4-(C6H5)phenyl 1.62 F H 3 5 phenyl
1.63 F H 3 4 4-CI-phenyl
1.64 F H 3 4 2,3,6-tri-F-phenyl
1.65 F H 3 4 4-Br-phenyl
1.66 F H 3 5 3-CH3-phenyl
1.67 F H 5 5 4-CH3-phenyl
1.68 F C2H5 4 5 2-NO2-4-(C6H5)phenyl
1.69 F C3H7-n 3 6 4-(C6H5)phenyl
1.70 F C4H9-n 3 6 phenyl
1.71 Cl C3H7-i 3 6 4-CI-phenyl
1.72 F C-2H5 3 6 2,3,6-tri-F-phenyl
1.73 F C4H9-s 2 6 4-Br-phenyl
1.74 Cl C4H9-t 1 2 3-CH3-phenyl
1.75 F C2H5 1 2 4-CH3-phenyl
1.76 F CH3 1 2 naphth-1-yl
1.77 F CH3 1 2 3-CI-naphth-1-yl
1.78 F CH3 1 3 naphth-2-yl
1.79 F CH3 1 3 1-CH3-naphth-2-yl
1.80 Cl C2H5 1 4 naphth-1-yl
1.81 F CH3 1 6 2,4-di-NO2-phenyl
1.82 F CH3 10 5 2,3,4,5,6-penta-F-phenyl
1.83 F CH3 9 5 3,5-di-NO2-phenyl
1.84 F C2H5 8 4 3-CF3-phenyl
1.85 Cl CH3 8 2 2-NO2-phenyl
1.86 F CH3 10 2 2-NH2-phenyl
Table 2: Compounds of formula I, wherein A stands for oxygen
No. Y X n m physical
-E*τ constant
2.1. F CH3 3 2 tetrahydro-pyran-2-yl nD" = 1.441
2.2. Cl CH3 3 2 tetrahydro-pyran-2-yl
2.3. F C2H5 3 2 tetrahydro-pyran-2-yl 2.4. Cl C2H5 3 2 tetrahydro-pyran-2-yl
2.5. F C3H7-n 3 2 tetrahydro-pyran-2-yl
2.6. F CH3 1 2 tetrahydro-pyran-2-yl
2.7. Cl CH3 1 2 tetrahydro-pyran-2-yl
2.8. F C2H5 2 2 tetrahydro-pyran-2-yl
2.9. Cl C2H5 2 2 tetrahydro-pyran-2-yl
2.10. F C3H7-n 3 2 tetrahydro-pyran-2-yl
2.11. F CH3 3 3 tetrahydro-pyran-2-yl
2.12. Cl CH3 3 3 tetrahydro-pyran-2-yl
2.13. F C2H5 3 4 tetrahydro-pyran-2-yl
2.14. Cl C2H5 3 4 tetrahydro-pyran-2-yl
2.15. F C3H7-n 3 6 tetrahydro-pyran-2-yl
2.16. F CH3 3 2 pyridin-2-yl
2.17. Cl CH3 3 2 pyridin-2-yl
2.18. F C2H5 3 2 5-CI-pyridin-2-yl
2.19. Cl C2H5 3 2 3-CI-pyridin-2-yl
2.20. F C3H7-n 3 2 1 ,2,4-triazin-3-yl
2.21. F CH3 3 2 6H-1 ,2,5-thiadiazin-6-yl
2.22. Cl CH3 3 2 1 ,3-thiazol-2-yl
2.23. F C2H5 3 2 1 ,2-oxothiolan-3-yl
2.24. Cl C2H5 3 2 thien-2-yl
2.25. F C3H7-n 3 2 5-CI-thien-2-yl
2.26. F CH3 3 2 fur-3-yl
2.27. Cl CH3 3 2 fur-2-yl
2.28. F C2H5 3 2 2H-pyran-3-yl
2.29. Cl C2H5 3 2 2H-pyran-3-yl
2.30. F C3H7-n 3 2 pyrrol-3-yl
2.31. F CH3 3 2 imidazol-2-yl
2.32. Cl CH3 3 2 pyrazol-3-yl
2.33. F C2H5 3 2 pyriazin-2-yl
It has since been possible to confirm the excellent insecticidal and acaricidal action of the substances disclosed in EP-0 577 555 in in vitro tests and in vivo also in the field of plant protection. By contrast, however, the use, suggested speculatively in EP-0 577 555, of the substances described therein for the protection of domestic animals and productive livestock has proved to be substantially inappropriate because the compounds trigger unacceptable side-effects when administered to productive livestock and domestic animals. The side-effects range from serious skin irritations and necroses to the death of the animals treated. That class of substance therefore appears to be completely unsuitable for use in the field of animal health.
Surprisingly, however, there has now been found a specific group of 5-halopent-4-enoic acid ethyl esters, namely the compounds of formula I defined at the outset, which does not cause those negative side-effects but, on the contrary, is excellently tolerated by productive livestock and domestic animals even in relatively large amounts and still has excellent activity against insects and representatives of the family of Acarina (arachnids, especially mites and ticks). These unforeseeable advantageous effects on warm-blooded animals could not have been foreseen in any way and, when applied to the field of animal health, can be exploited excellently in the control of ectoparasites. The advantageous effect is clearly associated with the specific chemical structure.
In the context of the present invention, ectoparasites are understood to mean in particular insects, mites and ticks. Included are insects of the following orders: Lepidoptera, Coleoptera, Homoptera, Heteroptera, Diptera, Thysanoptera, Orthoptera, Psoroptes, Anoplura, Siphonaptera, Mallophaga, Thysanura, Isoptera, Psocoptera and Hymenoptera. Special mention may be made, however, of ectoparasites that trouble humans and animals and transmit pathogens, for example flies, such as Musca domestica, Musca vetustissima, Musca autumnalis, Fannia canicularis, Sarcophaga camaria, Lucilia cuprina, Hypoderma bovis, Hypoderma lineatum, Chrysomyia chloropyga, Dermatobia hominis, Cochliomyia hominivorax, Gasterophilus intestinalis, Oestrus ovis, Stomoxys calcitrans, Haematobia irritans and midges (Nematocera), such as Culicidae, Simuliidae, Psychodidae, and also bloodsucking parasites, for example fleas, such as Ctenocephalides felis and Ctenocephalides canis (cat and dog fleas), Xenopsylla cheopis, Pulex irritans, Dermatophilus penetrans, lice, such as Damalina ovis, Pediculus humanis, stable flies and horse flies (Tabanidae), Haematopota spp., such as Haematopota pluvialis, Tabanidea spp., such as Tabanus nigrovittatus, Chrysopsinae spp., such as Chrysops caecutiens, tsetse flies, such as Glossinia species, biting insects, especially cockroaches, such as Blatella germanica, Blatta orientalis, Periplaneta americana, mites, such as Dermanyssus gallinae, Sarcoptes scabiei, Psoroptes ovis and Psorergates spp. and finally ticks. The latter belong to the order Acarina. Known examples of ticks are, for example, Boophilus, Amblyomma, Anocentor, Dermacentor, Haemaphysalis, Hyalomma, Ixodes, Rhipicentor, Margaropus, Rhipicephalus, Argas, Otobius and Ornithodoros and the like that preferentially infest warm-blooded animals, including farm animals, such as cows, pigs, sheep and goats, poultry, such as hens, turkeys and geese, animals bred for their fur, such as mink, fox, chinchillas, rabbits and the like, and domestic animals, such as cats and dogs, but also humans.
Ticks may be subdivided into hard and soft ticks and are characterised by the fact that they infest one, two or three host animals. They attach themselves to a suitable host animal and suck blood or body fluid. Fully replete female ticks fall off the host animal and lay large amounts of eggs (2000 to 3000) in a suitable niche in the ground or in any other protected site, where the larvae hatch out. These in turn look for a host animal from which to suck blood. Larvae of ticks that infest only one host animal moult twice and in so doing become nymphs and finally adult ticks without leaving the host animal initially selected. Larvae of ticks that infest two or three host animals fall off after the blood meal, moult in the surrounding area and, as nymphs or adult ticks, look for a second or third host on which to suck.
Ticks are responsible worldwide for carrying and transmitting many human and animal diseases. The most significant ticks, owing to their economic effect, are Boophilus, Rhipicephalus, Ixodes, Hyalomma, Amblyomma and Dermacentor. They are carriers of bacterial, viral, rickettsial and protozoal diseases and cause tick paralysis and tick toxicosis. Just a single tick can cause paralysis as a result of its saliva penetrating the host animal as the tick takes its nourishment. Diseases triggered by ticks are usually carried by ticks that infest a plurality of host animals. Such diseases, for example babesiosis, anaplasmosis and theileriosis, and pericardial fluid are responsible for the death of, or injury to, a large number of domestic and farm animals worldwide. In many countries having a temperate climate, ixodid ticks transmit the agent of chronically damaging Lyme disease from wild animals to humans. In addition to disease transmission, ticks are responsible for large-scale economic loss in livestock production. The losses are attributable not only to the death of the host animals but also to damage to the coat, growth loss, reduction in milk production and the reduced value of the meat. Although the damaging effects of tick infestation on animals have been known for years and enormous progress has been made with tick-control programmes, no completely satisfactory methods for the control or elimination of those parasites have hitherto been found and, furthermore, ticks have often developed resistance to chemical active substances.
The infestation of domestic animals and pets with fleas also still constitutes a problem for animal owners to which the solution is still only inadequate or very expensive. Like ticks, fleas are not only a nuisance but are also disease carriers, which, especially in moist-warm climatic regions, for example in the Mediterranean region, the southern part of the USA, etc., transmit various fungal diseases from host animal to host animal and to the animal keeper. Especially at risk are people having a weakened immune system or children whose immune system has not yet fully developed. Owing to the flea's complex life cycle, none of the known methods of controlling them is totally satisfactory, especially since most of the known methods are aimed principally at controlling the fully grown fleas in the coat and take no account at all of the various juvenile stages of the fleas, which live not only in the animal's coat, but also on the floor, on carpets, on the animal's sleeping place, on chairs, in the garden and in all the other places with which the infested animal comes into contact. Flea treatment is generally expensive and must be continued for prolonged periods, success generally being achieved only when the treatment is applied not only to the affected animal, for example the dog or cat, but also simultaneously to all the places frequented by the affected animal. The compounds of formula I are suitable both for the direct treatment of the animal and for the disinfection of its environment and, owing to the fact that it is well tolerated, also for the treatment of the animal's sleeping place.
The present invention accordingly preferably relates to a method of controlling parasites on domestic animals, productive livestock and pets, which method comprises administering an effective amount of a composition that comprises at least one compound of formula I or a physiologically tolerable salt thereof, preferably topically, to an infested warm-blooded animal for curative treatment or to a parasite-free warm-blooded animal for preventative treatment. Pour-on and spot-on formulations are especially preferred forms of topical administration, but administration in the form of sprays, ointments, solutions, baths or powders may also be expedient.
When used according to the invention, the compound of formula I according to the invention will normally be administered not in pure form but preferably in the form of a composition that comprises, in addition to the active ingredient, constituents that assist administration, suitable constituents being those which are tolerated by the host animal. The control according to the invention covers both the adult parasites and the juvenile stages of the parasites. Further active substances may of course be added to such compositions in order to broaden the spectrum of activity of the active ingredient.
Such compositions to be administered in accordance with the invention generally comprise from 0.1 to 99% by weight, especially from 0.1 to 95% by weight, of a compound of formula I according to the invention and from 99.9 to 1% by weight, especially from 99.9 to 5% by weight, of a solid or liquid, physiologically tolerable carrier, including from 0 to 25% by weight, especially from 0.1 to 25% by weight, of a non-toxic dispersant. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations.
Such compositions may comprise further additives, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as other active ingredients for obtaining special effects.
The physiologically tolerable carriers known from veterinary medicinal practice for oral, percutaneous and topical administration can be used as formulation auxiliaries. Some examples are given below.
Suitable carriers are especially fillers, such as sugars, for example lactose, saccharose, mannitol or sorbitol, cellulose preparations and/or calcium phosphates, for example tricalcium phosphate or calcium hydrogen phosphate, and binders, such as starch pastes using, for example, maize, wheat, rice or potato starch, gelatins, tragacanth, methyl cellulose and/or, if desired, disintegrators, such as the above-mentioned starches, also carboxymethyl starch, crosslinked polyvinylpyrrolidone, agar, alginic acid or a salt thereof, such as sodium alginate. Adjuvants are especially flow regulators and lubricants, for example silicic acid, talc, stearic acid or salts thereof, such as magnesium or calcium stearate, and/or polyethylene glycol. Dragee cores can be provided with suitable, optionally enteric, coatings, there being used, inter alia, concentrated sugar solutions which may comprise gum arabic, talc, polyvinylpyrrolidone, polyethylene glycol and/or titanium dioxide, or coating solutions in suitable organic solvents or solvent mixtures or, for the preparation of enteric coatings, solutions of suitable cellulose preparations, such as acetyl cellulose phthalate or hydroxypropylmethylcellulose phthalate. Dyes, flavourings or pigments may be added to the tablets or dragee coatings, for example for identification purposes or to indicate different doses of active ingredient.
The preferred pour-on or spot-on method comprises applying the compound of formula I to a locally defined area of the skin or coat, advantageously on the back of the neck or the backbone of the animal. This is carried out, for example, by applying a swab or squirt of the pour-on or spot-on formulation to a relatively small area of the coat from where the active ingredient becomes distributed over a wide area of the coat almost automatically, as a result of the spreading constituents of the formulation and assisted by the movements of the animal.
Pour-on and spot-on formulations advantageously comprise carriers that promote rapid distribution over the surface of the skin or in the coat of the host animal and are generally termed spreading oils. There are suitable, for example, oily solutions; alcoholic and isopropanolic solutions, e.g. solutions of 2-octyldodecanol or oleyl alcohol; solutions in esters of monocarboxylic acids, such as isopropyl myristate, isopropyl palmitate, lauric acid oxalic ester, oleic acid oleyl ester, oleic acid decyl ester, hexyl laurate, oleyl oleate, decyl oleate, capric acid esters of saturated fatty alcohols of chain length Cι2-C18; solutions of esters of dicarboxylic acids, such as dibutyl phthalate, diisopropyl isophthalate, adipic acid diisopropyl ester, di-n-butyl adipate or solutions of esters of aliphatic acids, e.g. glycols. It may be advantageous for a dispersant known from the pharmaceutical or cosmetic industry also to be present. Examples are pyrrolidin-2-one, N-alkylpyrrolidin-2-one, acetone, polyethylene glycol and its ethers and esters, propylene glycol and synthetic triglycerides. Th e oily solutions include e.g. vegetable oils, such as olive oil, groundnut oil, sesame oil, pine oil, linseed oil and castor oil. The vegetable oils may also be in epoxidised form. It is also possible to use paraffins and silicone oils.
Generally a pour-on or spot-on formulation will contain from 1 to 20% by weight of a compound of formula (I), from 0.1 to 50% by weight of dispersant and from 45 to 98.9% by weight of solvent.
The pour-on or spot-on method can be used especially advantageously for herd animals, such as cattle, horses, sheep and pigs, where it is difficult or time-consuming to treat all the animals orally or via injection. By virtue of its simplicity, this method can of course also be used for all other animals, including individual domestic animals and pets, and is very popular with the keepers of animals because it can often be carried out without the expert assistance of a veterinary surgeon.
The preparations of the present invention can be prepared in a manner known per se, for example by means of conventional processes. The following Examples and patent claims illustrate the invention described above but do not limit its scope in any way. Temperatures are given in degrees Celsius. In the following Formulation Examples, the expression "compound of formula I" denotes a compound from the Tables, especially 4-methyl-5,5- difluoropent-4-enoic acid (3-methyl-phenoxy)ethyl ester.
Formulation Examples Example: Pour-on
A. compound of formula I 10% epoxidised soybean oil 5% oleyl alcohol 85% B. compound of formula I 20% pyrrolidin-2-one 15% isopropyl myristate 65%
compound of formula I 5 g isopropyl myristate 10 g isopropanol ad 100 ml
D. compound of formula I 2 g hexyl laurate 5 g medium-chain triglycerides 15 g ethanol ad 100 ml
compound of formula 2 g oleyl oleate 5 g N-methyl-pyrrolidone 40 g isopropanol ad 100 ml
Dustable powders 25 parts by weight compound of formula I 1 part by weight sodium lauryl sulfate, 3 parts by weight colloidal silica gel, and 71 parts by weight urea.
The constituents are mixed and ground with one another until homogeneous. Suspension concentrates: compound of formula I : from 5 to 75 %, preferably from 10 to 50 % water: from 94 to 24 %, preferably from 88 to 30 % surfactant: from 1 to 40 %, preferably from 2 to 30 %
Further biologically active substances or additives that behave neutrally towards the compounds of formula I and have no detrimental effect upon the host animal to be treated, as well as mineral salts or vitamins may be added to the compositions described.
The compositions may also comprise further additives, such as stabilisers, e.g. vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rape oil or soybean oil), antifoams, e.g. silicone oil, preservatives, viscosity regulators, binders and tackifiers, as well as fertilisers, or other active ingredients for obtaining special effects.
Further preparations comprising active ingredients of formula I can also be prepared analogously to the formulations described.
The compounds of formula I according to the invention can be used alone or in combination with other biocides. For example, in order to enhance their effect they can be combined with pesticides having the same direction of action or in order to broaden the spectrum of activity they can be combined with substances having a different direction of action. It may also be advantageous to add repellents. Where it is desired to broaden the spectrum of activity to endoparasites, e.g. worms, the compounds of formula I are advantageously combined with substances having endoparasiticidal properties. They can, of course, also be used in combination with anti-bacterial compositions. Since the compounds of formula I are "adulticides", that is to say they are effective especially against the fully grown stages of the target parasites, it can be highly advantageous to add pesticides that attack the juvenile stages of the parasite as well. In that manner most of the parasites causing substantial economic damage are targeted. This also helps considerably in avoiding the development of resistance. Some combinations can also produce synergistic effects, which means that the total amount of active substance used can be reduced, which is desirable from the ecological standpoint. Preferred groups of combination partners and especially preferred combination partners are mentioned hereinbelow, it being possible for combinations to comprise, in addition to a compound of formula I, one or more such partners.
Suitable mixing partners are biocides, such as the insecticides and acaricides mentioned hereinbelow that are sufficiently well known to the person skilled in the art and that have various action mechanisms, e.g. chitin synthesis inhibitors, growth regulators; active ingredients that act like juvenile hormones; active ingredients that act as adulticides; broad- spectrum insecticides, broad-spectrum acaricides and nematicides; and also the sufficiently well known anthelmintics and substances that repel insects and/or acarina, so-called repellents and detachers. Non-limiting examples of suitable insecticides and acaricides are:
(I) aldicarb; (XVIII) ethiofencarb; (XXXV) teflubenzuron;
(II) azinphos-methyl; (XIX) fenitrothion; (XXXVI) terbufos;
(III) benfuracarb; (XX) fenobucarb; (XXXVII) triazamate;
(IV) bifenthrin; (XXI) fenvalerate; (XXXVIII) abamectin;
(V) buprofezin; (XXII) formothion; (XXXIX) fenobucarb;
(VI) carbofuran; (XXIII) methiocarb; (XL) tebufenozide;
(VII) dibutylaminothio; (XXIV) heptenophos; (XLI) fipronil;
(VIII) cartap; (XXV) imidacloprid; (XLII) beta-cyfluthrin;
(IX) chlorfluazuron; (XXVI) isoprocarb; (XLIII) silafluofen;
(X) chlorpyrifos; (XXVII) methamidophos; (XLIV) fenpyroximate;
(XI) cyfluthrin; (XXVIII) methomyl; (XLV) pyridaben;
(XII) lambda-cyhalothrin; (XXIX) mevinphos; (XLVI) fenazaquin;
(XIII) alpha-cypermethrin; (XXX) parathion; (XLVII) pyriproxyfen;
(XIV) zeta-cypermethrin; (XXXI) parathion-methyl; (XLVIII) pyrimidifen;
(XV) deltamethrin; (XXXII) phosalone; (XLIX) nitenpyram;
(XVI) diflubenzuron; (XXXIII) pirimicarb; (L) NI-25, acetamiprid;
(XVII) endosulfan; (XXXIV) propoxur;
(LI) avermectin B^
(Lll) an insect-active extract from a plant;
(Llll) a preparation comprising insect-active nematodes;
(LIV) a preparation obtainable from Bacillus subtilis;
(LV) a preparation comprising insect-active fungi; (LVI) a preparation comprising insect-active viruses;
(LVI!) AC 303 630; (LXXXVIII) demeton-M; (CXX) hexythiazox;
(LVIII) acephate; (LXXXIX) demeton-S; (CXXI) iprobenfos;
(LIX) acrinathrin; (XC) demeton-S-methyl; (CXXII) isofenphos;
(LX) alanycarb; (XCI) dichlofenthion; (CXXIII) isoxathion;
(LXI) alphamethrin; (XCII) dicliphos; (CXXIV) ivermectin;
(LXII) amitraz; (XCIII) diethion; (CXXV) lambda-
(LXIII) AZ 60541 ; (XCIV) dimethoate; cyhalothrin;
(LXIV) azinphos A; (XCV) dimethylvinphos; (CXXVI) malathion;
(LXV) azinphos M; (XCVI) dioxathion; (CXXVII) mecarbam;
(LXVI) azocyclotin; (XCVII) edifenphos; (CXXVIII) mesulfenphos;
(LXVII) bendiocarb; (XCVIII) emamectin; (CXXIX) metaldehyde;
(LXVIII) bensultap; (XCIX) esfenvalerate; (CXXX) metolcarb;
(LXIX) beta-cyfluthrin; (C) ethion; (CXXXI) milbemectin;
(LXX) BPMC; (Cl) ethofenprox; (CXXXII) moxidectin;
(LXXI) brofenprox; (Cll) ethoprophos; (CXXXIII) naled;
(LXXII) bromophos A; (Clll) etrimphos; (CXXXIV) NC 184;
(LXXIII) bufencarbe; (CIV) fenamiphos; (CXXXV) omethoate;
(LXXIV) butocarboxin; (CV) fenbutatine oxide; (CXXXVI) oxamyl;
(LXXV) butylpyridaben; (CVI) fenothiocarb; (CXXXVII) oxydeme-
(LXXVI) cadusafos; (CVII) fenpropathrin; thon M;
(LXXVII) carbaryl; (CVIII) fenpyrad; (CXXXVIII) oxydeprofos;
(LXXVIII) carbopheno- (CIX) fenthion; (CXXXIX) permethrin; thion; (CX) fluazinam; (CXL) phenthoate; (LXXIX) chloethocarb; (CXI) flucycloxuron; (CXLI) phorate; (LXXX) chlorethoxyfos; (CXII) flucythrinate; (CXLII) phosmet; (LXXXI) chlormephos; (CXIII) flufenoxuron; (CXLIII) phoxim; (LXXXII) cis-res-methrin; (CXIV) flufenprox; (CXLIV) pirimiphos M; (LXXXIII) clocythrin; (CXV) fonophos; (CXLV) pirimiphos A; (LXXXIV) clofentezin; (CXVI) fosthiazate; (CXLVI) promecarb; (LXXXV) cyanophos; (CXVII) fubfenprox; (CXLVII) propaphos; (LXXXVI) cycloprothrin; (CXVIII) HCH; (CXLVIII) prothiofos; (LXXXVII) cyhexatin; (CXIX) hexaflumuron; (CXLIX) prothoate; (CL) pyrachlophos; (CLXXXII) RH-2485; (CLI) pyridaphenthion; (CLXXXIII) D 2341 ; (CLII) pyresmethrin; (CLXXXIV) XMC (3,5-xy- (CLIII) pyrethrum; lyl methylcarbamate), (CLIV) RH 5992; (CLXXXV) lufenuron (CLV) salithion; (CLXXXVI) fluazuron (CLVI) sebufos; (CLXXXVII) methoprene (CLVII) sulfotep; (CLXXXVIII) hydroprene (CLVIII) sulprofos; (CLXXXIX) fenoxycarb (CLIX) tebufenpyrad; (CXC) chlorfenapyr or (CLX) tebupirimphos; (CXCI) spinosad (CLXI) tefluthrin; (CXCII) thiamethoxam (CLXII) temephos; (CLXIII) terbam; (CLXIV) tetrachlor- vinphos; (CLXV) thiafenox; (CLXVI) thiodicarb; (CLXVII) thiofanox; (CLXVIII) thionazin; (CLXIX) thuringiensin; (CLXX) traiomethrin; (CLXXI) triarthen; (CLXXII) triazophos; (CLXXIII) triazuron; (CLXXIV) trichlorfon; (CLXXV) triflumuron; (CLXXVI) trimethacarb; (CLXXVII) vamidothion; (CLXXVIII) xylylcarb; (CLXXIX) Yl 5301/5302; (CLXXX) zetamethrin; (CLXXXI) DPX-MP062; Non-limiting examples of suitable anthelmintics are mentioned hereinbelow, a number of the examples thereof having, in addition to anthelmintic activity, also an insecticidal and acaricidal activity, some of them already being mentioned in the list above: (AD praziquantel = 2-cyclohexylcarbonyl-4-oxo-1 ,2,3,6,7,1 1 b-hexahydro-4H-pyrazino[2,1- αjisoquinoline (A2) closantel = 3,5-diiodo-N-[5-chloro-2-methyl-4-(α-cyano-4-chlorobenzyl)phenyl]salicyl- amide (A3) triclabendazole = 5-chloro-6-(2,3-dichlorophenoxy)-2-methylthio-1 H-benzimidazole (A4) levamisol = Z_-(-)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1 b]thiazole (A5) mebendazole = (5-benzoyl-1 H-benzimidazol-2-yl)carbamic acid methyl ester (A6) omphalotin = a macrocyclic fermentation product of the fungus Omphalotus olearius described in WO 97/20857 (A7) abamectin = avermectin B1 (A8) ivermectin = 22,23-dihydroavermectin B1 (A9) moxidectin = 5-O-demethyl-28-deoxy-25-(1 ,3-dimethyl-1 -butenyl)-6,28-epoxy-23-
(methoxyimino)-milbemycin B (A10) doramectin = 25-cyclohexyl-5-O-demethyl-25-de(1 -methylpropyl)-avermectin A1a (A1 1 ) milbemectin = mixture of milbemycin A3 and milbemycin A4 (A12) milbemvcinoxim = 5-oxime of milbemectin
Non-limiting examples of suitable repelling substances (repellents and detachers) are:
(RD DEET (N,N-diethyl-m-toluamide)
(R2) KBR 3023 N-butyl-2-oxycarbonyl-(2-hydroxy)-piperidine
(R3) cymiazole = N,-2,3-dihydro-3-methyl-1 ,3-thiazol-2-ylidene-2,4-xylidene
The mentioned mixing partners are well known to persons skilled in the art. Most of them are described in various editions of the Pesticide Manual, The British Crop Protection Council, London, while others are described in various editions of The Merck Index, Merck & Co., Inc., Rahway, New Jersey, USA or in the patent literature. The following list is therefore restricted to a few references given by way of example.
(I) 2-methyl-2-(methylthio)propionaldehyde O-methylcarbamoyloxime (aldicarb), from The Pesticide Manual, 11th Ed. (1997), The British Crop Protection Council, London, page 26; (II) S-(3,4-dihydro-4-oxobenzo[o]-[1 ,2,3]-triazin-3-ylmethyl) O,O-dimethyl phosphorodithioate (azinphos-methyl), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 67;
(III) ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl-(methyl)aminothio]-N- isopropyl-β-alaninate (benfuracarb), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 96;
(IV) 2-methylbiphenyl-3-ylmethyl (2)-(1 ?S)-c/s-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2- dimethylcyclopropanecarboxylate (bifenthrin), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 118;
(V) 2-tert-butylimino-3-isopropyl-5-phenyl-1 ,3,5-thiadiazinan-4-one (buprofezin), from The Pesticide Manual, 11,hEd. (1997), The British Crop Protection Council, London, page 157;
(VI) 2,3-dihydro-2,2-dimethylbenzofuran-7-yl methylcarbamate (carbofuran), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 186;
(VII) 2,3-dihydro-2,2-dimethylbenzofuran-7-yl (dibutylaminothio)methylcarbamate (carbosulfan), from The Pesticide Manual, 11,hEd. (1997), The British Crop Protection Council, London, page 188;
(VIII) S,S,-(2-dimethylaminotrimethylene) bis(thiocarbamate) (cartap), from The Pesticide Manual, 11 lhEd. (1997), The British Crop Protection Council, London, page 193;
(IX) 1-[3,5-dichloro-4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl]-3-(2,6-difluorobenzoyl)- urea (chlorfluazuron), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 213;
(X) 0,Odiethyl 03,5,6-trichloro-2-pyridyl phosphorothioate (chlorpyrifos), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 235;
(XI) (r?S)-α-cyano-4-fiuoro-3-phenoxybenzyl (1 RS,3RS;-\ r?S,3/:?S)-3-(2,2-dichlorovinyl)-2,2- dimethylcyclopropanecarboxylate (cyfluthrin), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 293;
(XII) mixture of (S)-α-cyano-3-phenoxybenzyl (Z)-(1 fl,3/?)-3-(2-chloro-3,3)3-trifluoro- propenyl)-2,2-dimethylcyclopropanecarboxylate and (/^-α-cyano-S-phenoxybenzyl (2)- (1 f?,3fl)-3-(2-chloro-3,3)3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (lambda-cyhalothrin), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 300;
(XIII) racemate consisting of (S)-α-cyano-3-phenoxybenzyl (1 R,3fl)-3-(2,2-dichlorovinyl)-2,2- dimethylcyclopropanecarboxylate and ( ?)-α-cyano-3-phenoxybenzyl (1 S,3S)-3-(2,2- dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (alpha-cypermethrin), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 308;
(XIV) a mixture of the stereoisomers of (S)-α-cyano-3-phenoxybenzyl (1 RS,3flS,1 RS,3RS)- 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (zeta-cypermethrin), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 314;
(XV) (S)-α-cyano-3-phenoxybenzyl (1 fl,3fl)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane- carboxylate (deltamethrin), from The Pesticide Manual, 1 1,hEd. (1997), The British Crop Protection Council, London, page 344;
(XVI) (4-chlorophenyl)-3-(2,6-difluorobenzoyl)urea (diflubenzuron), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 395;
(XVII) (1 ,4,5,6,7,7-hexachloro-8,9,10-trinorbom-5-en-2,3-ylenebismethylene) sulfite (endosulfan), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 459;
(XVIII) α-ethylthio-o-tolyl methylcarbamate (ethiofencarb), from The Pesticide Manual, 11,hEd. (1997), The British Crop Protection Council, London, page 479;
(XIX) 0,0-dimethyl 0-4-nitro-m-tolyl phosphorothioate (fenitrothion), from The Pesticide Manual, 11t Ed. (1997), The British Crop Protection Council, London, page 514;
(XX) 2-sec-butylphenyl methylcarbamate (fenobucarb), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 516;
(XXI) (f?S)-α-cyano-3-phenoxybenzyl (f?S)-2-(4-chlorophenyl)-3-methylbutyrate (fenvalerate), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 539;
(XXII) S-[formyl(methyl)carbamoylmethyl] 0,Odimethyl phosphorodithioate (formothion), from The Pesticide Manual, 1 1t Ed. (1997), The British Crop Protection Council, London, page 625;
(XXIII) 4-methylthio-3,5-xylyl methylcarbamate (methiocarb), from The Pesticide Manual, H^Ed. (1997), The British Crop Protection Council, London, page 813; (XXIV) 7-chlorobicyclo[3.2.0]hepta-2,6-dien-6-yl dimethylphosphate (heptenophos), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 670;
(XXV) 1 -(6-chloro-3-pyridylmethyl)-Λ/-nitroimidazolidin-2-ylidenamine (imidacloprid), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 706;
(XXVI) 2-isopropylphenyl methylcarbamate (isoprocarb), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 729;
(XXVII) 0,S-dimethyl phosphoramidothioate (methamidophos), from The Pesticide Manual, 11lhEd. (1997), The British Crop Protection Council, London, page 808;
(XXVIII) S-methyl Λ/-(methylcarbamoyloxy)thioacetimidate (methomyl), from The Pesticide Manual, 1 1 hEd. (1997), The British Crop Protection Council, London, page 815;
(XXIX) methyl 3-(dimethoxyphosphinoyloxy)but-2-enoate (mevinphos), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 844;
(XXX) 0,0-diethyl O-4-nitrophenyl phosphorothioate (parathion), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 926;
(XXXI) 0,0-dimethyl O-4-nitrophenyl phosphorothioate (parathion-methyl), from The Pesticide Manual, 1 1,hEd. (1997), The British Crop Protection Council, London, page 928;
(XXXII) S-6-chloro-2,3-dihydro-2-oxo-1 ,3-benzoxazol-3-ylmethyl 0,0-diethyl phosphorodithioate (phosalone), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 963;
(XXXIII) 2-dimethylamino-5,6-dimethylpyrimidin-4-yl dimethylcarbamate (pirimicarb), from The Pesticide Manual, 11,hEd. (1997), The British Crop Protection Council, London, page 985;
(XXXIV) 2-isopropoxyphenyl methylcarbamate (propoxur), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1036;
(XXXV) 1-(3,5-dichloro-2,4-difluorophenyl)-3-(2,6-difluorobenzoyl)urea (teflubenzuron), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1158;
(XXXVI) S-tert-butylthiomethyl 0,0-dimethyl phosphorodithioate (terbufos), from The Pesticide Manual, 1 1^Ed. (1997), The British Crop Protection Council, London, page 1165; (XXXVII) ethyl (3-fert-butyl-1-dimethylcarbamoyl-1 H-1 ,2,4-triazol-5-yl-thio)-acetate, (triazamate), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1224;
(XXXVIII) abamectin, from The Pesticide Manual, 11 hEd. (1997), The British Crop Protection Council, London, page 3;
(XXXIX) 2-sec-butylphenyl methylcarbamate (fenobucarb), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 516;
(XL) /V-terf-butyl-/V -(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide (tebufenozide), from The
Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1147; (XLI) (±)-5-amino-1 -(2,6-dichloro-α,α,α-trifluoro-p-tolyl)-4-trifluoromethyl-sulfinylpyrazole-3- carbonitrile (fipronil), from The Pesticide Manual, 1 1lhEd. (1997), The British Crop
Protection Council, London, page 545; (XLII) (r?S)-α-cyano-4-fluoro-3-phenoxybenzyl (1 RS,3f?S;1 RS,3flSj-3-(2,2-dichlorovinyl)-
2,2-dimethylcyclopropanecarboxylate (beta-cyfluthrin), from The Pesticide Manual,
11,hEd. (1997), The British Crop Protection Council, London, page 295; (XLIII) (4-ethoxyphenyl)-[3-(4-fluoro-3-phenoxyphenyl)propyl](dimethyl)silane (silafluofen), from The Pesticide Manual, 1 1 hEd. (1997), The British Crop Protection Council, London, page 1 105; (XLIV) .erf-butyl (E)-α-(1 ,3-dimethyl-5-phenoxypyrazol-4-yl-methylenamino-oxy)-p-toluate
(fenpyroximate), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection
Council, London, page 530; (XLV) 2-tert-butyI-5-(4-terf-butylbenzylthio)-4-chloropyridazin-3(2/-/)-one (pyridaben), from
The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page
1161 ; (XLVI) 4-[[4-(1 ,1-dimethylphenyl)phenyl]ethoxy]-quinazoline (fenazaquin), from The
Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 507; (XLVII) 4-phenoxyphenyl (f?S)-2-(pyridyloxy)propyl ether (pyriproxyfen), from The Pesticide
Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 1073; (XLVIII) 5-chloro-Λ/-{2-[4-(2-ethoxyethyl)-2,3-dimethylphenoxy]ethyl}-6-ethylpyrimidin-4- amine (pyrimidifen), from The Pesticide Manual, 11,hEd. (1997), The British Crop
Protection Council, London, page 1070; (XLIX) (E)-/V-(6-chloro-3-pyridylmethyl)-/V-ethyl-/V-methyl-2-nitrovinylidenediamine (nitenpyram), from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 880;
(L) (^-^-[(e-chloro-S-pyridylJmethylj-Λ^-cyano-Λ/^methylacetamidine (NI-25, acetamiprid), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 9;
(LI) avermectin B from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 3;
(Lll) an insect-active extract from a plant, especially (2r?,6aS,12aS)-1 ,2,6,6a,12,12a- hexahydro-2-isopropenyl-8,9-dimethoxy-chromeno[3,4-£)]furo[2,3-A7]chromen-6-one (rotenone), from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council, London, page 1097; and an extract from Azadirachta indica, especially azadirachtin, from The Pesticide Manual, 11lhEd. (1997), The British Crop Protection Council, London, page 59; and
(LIN) a preparation comprising insect-active nematodes, preferably Heterorhabditis bacteriophora and Heterorhabditis megidis, from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 671 ; Steinernema feltiae, from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1115, and Steinernema scapterisci, from The Pesticide Manual, 11,hEd. (1997), The British Crop Protection Council, London, page 1116;
(LIV) a preparation obtainable from Bacillus subtilis, from The Pesticide Manual, 11,hEd. (1997), The British Crop Protection Council, London, page 72; or from a Bacillus thuringiensis strain with the exception of compounds isolated from GC91 or from NCTC11821 ; The Pesticide Manual, 11,hEd. (1997), The British Crop Protection Council, London, page 73;
(LV) a preparation comprising insect-active fungi, preferably Verlicillium lecanii, from The Pesticide Manual, 1 1, Ed. (1997), The British Crop Protection Council, London, page 1266; Beauveria brogniartii, from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 85; and Beauveria bassiana, from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 83;
(LVI) a preparation comprising insect-active viruses, preferably Neodipridon Sertifer NPV, from The Pesticide Manual, 11thEd. (1997), The British Crop Protection Council, London, page 1342; Mamestra brassicae NPV, from The Pesticide Manual, 11 Ed. (1997), The British Crop Protection Council, London, page 759; and Cydia pomonella granulosis virus, from The Pesticide Manual, 1 1thEd. (1997), The British Crop Protection Council,
London, page 291 ; (CLXXXI) 7-chloro-2,3,4a,5-tetrahydro-2-[methoxycarbonyl(4-trifluoromethoxyphenyl)- carbamoyl]indole[1 ,2e]oxazoline-4a-carboxylate (DPX-MP062, indoxycarb), from The
Pesticide Manual, 1 11hEd. (1997), The British Crop Protection Council, London, page 453; (CLXXXII) N-tert-butyl-N-(3,5-dimethylbenzoyl)-3-methoxy-2-methylbenzohydrazide
(RH-2485, methoxyfenozide), from The Pesticide Manual, 1 1thEd. (1997), The British
Crop Protection Council, London, page 1094; and (CLXXXIII) (Λ/'-[4-methoxy-biphenyl-3-yl]-hydrazinecarboxylic acid isopropyl ester (D 2341), from the Brighton Crop Protection Conference, 1996, 487- 493; (R2) Book of Abstracts, 212th ACS National Meeting Orlando, FL, August 25-29 (1996),
AGRO-020. Publisher: American Chemical Society, Washington, D.C. CONEN: 63BFAF.
Given the above, a further substantial aspect of the present invention relates to combination preparations for the control of parasites in or on warm-blooded animals, which combination preparations comprise, in addition to a compound of formula I, at least one further active ingredient having the same direction of action or a different direction of action and at least one physiologically tolerable carrier. The present invention is not limited to combinations of two constituents.
Biological Examples
Example 1 : Tolerability study on sheep after pour-on application
Completely healthy female sheep aged 4 to 5 months and having a body weight of approximately from 33 to 34 kg are shorn bald on the back and, for the purpose of clear identification, are provided with numbered eartags; for the entire duration of the test they are kept in separate pens with slatted floors. A small group remains untreated and serves as the control. All the sheep are given the customary standard feed apportioned according to their age, and water as desired. On day 0, from 33 to 34 ml of a pour-on formulation according to Example B (50 mg of test substance/kg of body weight) are applied to the back of each sheep. In order to detect any unusual behaviour or local side-effects, the sheep are observed continuously on the day of treatment. Blood samples are taken 6 hours after treatment and once each morning on the days that follow and are evaluated according to the following parameters.
Blood values Chemical values erythrocytes (RBC) aspartate aminotransferase (ASAT) haemoglobin (HB) alanine aminotransferase (ALAT) mean cell volume (HCT) creatine kinase (CK/NAC) mean cell-haemoglobin (MCH) γ-glutamate transpeptidase (G-GT) mean cell-haemoglobin concentration total bilirubin (TBILI)
(MCHC) leucocytes (WBC) creatinine (CREA) blood platelets (PLT) glucose (GLUC) blood platelets (PLT) glutamate dehydrogenase (GLDH) blood-urea-nitrogen (BUN) total protein (TOT. PROTEIN) albumin (ALB) globulin (GLOB) sodium (NA) potassium (K) calcium (CA) magnesium (MG)
After pour-on application, the test substances do not at any time prove to cause local side- effects and the blood and chemical values measured show a range of variation absolutely identical to that for the untreated control animals. The compounds of formula I, e.g. compounds nos. 1.1-1.8, 1.39 and 2.1 , prove to be well tolerated up to a dose of 100 mg/kg under the test conditions.
Example 2: In vivo activity against mange mites on sheep after pour-on application Healthy sheep having an average body weight of approximately 35 kg are artificially infested, between the shoulder blades and in the groin area, with mange (Psoroptes ovis) of all stages of development. After 3 weeks, approximately 90% of the sheep have infested areas of skin of about 25 - 50 cm2. The infested sheep are selected for the remaining tests and, in order to be able to distinguish clearly between them, they are provided with numbered eartags. For the entire duration of the test, the sheep are kept in individual pens (0.9 x 1.2 m) having a slatted grid floor. They are fed with approximately 0.7 kg of maize and approximately 0.2 kg of hay per day and have access to drinking water. 8 sheep are treated; 2 remain untreated and serve as the control group. An aqueous emulsion having a final concentration of test substance of 500 ppm is used for the treatment. The treatment is carried out by careful wetting of the infested sites, care being taken to ensure that the emulsion wets the wool and also the underlying areas of skin thoroughly. Approximately 1 litre of emulsion is used per sheep. The effectiveness of the test substances is assessed at 14-day intervals over a period of from 6 to 8 weeks by reference to the extent of the infested regions. The changes are assessed in relation to the situation at the outset, with the infestation directly before the start of treatment representing 100%. In parallel, the behaviour of the test animals is recorded. Completely analogous tests are carried out with dilute test emulsions (100 ppm).
The evaluation shows that, at a concentration of 500 ppm, compounds of formula I from Tables 1 and 2 completely eliminate the infestation within a maximum of 48 days, i.e. no surviving mites can be found and the damaged areas of skin show the healing process to be progressing. With a number of examples, e.g. compound nos. 1.1 -1.8, 1.39 and 2.1 , this result is achieved even at a dilution of the test substance to 100 ppm. None of the treated animals exhibits undesirable side-effects; they behave absolutely normally throughout the entire duration of the test.
Example 3: In vivo action against mouse mites by topical treatment
Mice infested with mites (Myocopetes musculinus and Myobia musculi) are anaesthetised and studied under a stereomicroscope to determine the density of the mite population. The mice are divided into groups having the same index of infestation, that is to say each having the same mite population, the index consisting of a scale from 1 (no mites) to 30 (greatest mite density). For the purposes of the test, only mice that score at least 25 on the said scale (high mite density) are used. The test substance is applied to the coat in the form of a solution, suspension or emulsion as a pour-on formulation, that is to say, topically. The dose is in the range from 32 to 0.1 mg/kg of body weight. 150 μl of the solution, suspension or emulsion are applied to each mouse along the line of the back. The effectiveness is evaluated 7, 28 and 56 days after application by comparing the infestation index after treatment with that before treatment. The effectiveness result is given as a percentage reduction in the mite population. In this test, compounds of formula I, such as, for example, compounds nos. 1.1-1.8, 1.39 and 2.1 , at a dilution of up to 10 mg/kg of body weight, exhibit a more than 80% reduction in mite infestation and show no negative side-effects even at the highest active ingredient concentrations.

Claims

What is claimed is:
1. A compound of formula I
Figure imgf000034_0001
wherein X is hydrogen, halogen, phenyl or C1-4alkyl;
Y is fluorine or chlorine;
A is -O-, -S- or -N(R1)-, wherein Ri is C1-4alkyl, phenylthio or tolylthio; n is from 1 to 12; m is from 2 to 6;
R is hydrogen or one of the groups
Figure imgf000034_0002
wherein Het is a saturated or unsaturated, 3- to 7-membered heterocyclic ring that optionally additionally comprises O or S as further hetero atom or the hetero group -N(Cι-6alkyl)- ; Aryl is phenyl or naphthyl; and R2, R3, R4, R5, R6, R7 and R8 are each independently of the others hydrogen, Cι-4alkyl, Cι- alkoxy, Cι-4alkylthio, d-4haloalkyl, C2.6alkenyl, C2.6alkynyl, halogen, hydroxy, cyano, nitro, phenyl, amino, C1- alkylamino, (Cι-4alkyl)2amino, Cι.4alkylsulfonyl or arylsulfonyl; in free form or in the form of a physiologically tolerable salt.
2. A compound of formula I according to claim 1 , wherein X is hydrogen, halogen or methyl; Y is fluorine or chlorine; A is -O- ; n is from 1 to 6; m is 2 or 3;
R is
Figure imgf000034_0003
, wherein Aryl is phenyl; and R > R5, R8, R7 and R8 are each independently of the others hydrogen, Cι.4alkyl, Cι.4alkoxy, d.4alkylthio,
Figure imgf000034_0004
halogen, hydroxy, cyano, nitro, phenyl, amino, Cι-4alkylamino, (Cι.4aikyl)2amino, Ci-talkylsulfonyl or arylsulfonyl; in free form or in the form of a physiologically tolerable salt.
3. A compound of formula I according to claim 1 , wherein X is hydrogen, halogen or Cι-4alkyl; Y is fluorine or chlorine; A is -O- ; n is from 1 to 6; m is from 2 to 4;
R is the group
Figure imgf000035_0001
; wherein Het is oxirane, aziridine, 2H-azepine, dioxolane, pyrrolidine, piperidine, morpholine, pyridine, pyrrole, furan, thiene, imidazole, tetrahydrofuran, tetrahydropyran, dihydrofuran, dihydropyran, isoxazole, oxazole, thiazole, oxazoline, oxazolidine, imidazoline, imidazolidine or dioxane; and R2 and R3 are each independently of the other hydrogen, C1-4alkyl, Cι.4alkoxy, Cι.4alkylthio, Cι. haloalkyl, C2-6alkenyl, C2.6alkynyl, halogen, hydroxy, cyano, nitro, phenyl, amino, C1.4alkylamino, (C1. alkyl)2amino, Cι-4alkyl- sulfonyl or arylsulfonyl; in free form or in the form of a physiologically tolerable salt.
4. A compound of formula I according to claim 2, wherein R4, R5, R6, R7 and R8 are each independently of the others hydrogen, fluorine, chlorine, methyl, methoxy, trifluoromethyl, cyano or nitro.
5. A compound of formula I according to claim 2, wherein R2 and R3 are each independently of the other hydrogen, fluorine, chlorine, methyl, methoxy, trifluoromethyl, cyano or nitro.
6. A process for the preparation of a compound of formula I according to any one of claims 1 to 5, which comprises reacting a compound of formula II
Figure imgf000035_0002
wherein X, Y and n are as defined for formula I and Q is hydroxy or halogen, preferably chlorine or bromine, in the presence or absence of an inert solvent or solvent mixture, with a compound of formula III
(CH2)m R wherein R, A and m are as defined for formula I; the reaction preferably being carried out in the presence of a hydrophilic agent or of a catalyst when Q is hydroxy, and preferably being carried out in the presence of an acid-binding agent when Q is halogen.
7. A composition for controlling ectoparasites on a domestic animal, productive livestock or a pet, which comprises, in addition to inert auxiliaries and carriers, at least one compound of formula I according to claim 1 as active ingredient.
8. A process for the preparation of a composition according to claim 7, which comprises intimately mixing a compound of formula I according to claim 1 with inert auxiliaries and carriers.
9. A method of controlling ectoparasites on a domestic animal, productive livestock or pet, which comprises applying a compound according to any one of claims 1 to 5 or a composition according to claim 7 to the ectoparasites or to their habitat.
10. A method according to claim 9, which comprises applying a compound of formula I according to any one of claims 1 to 5 in the form of a pour-on formulation to the coat of a domestic animal, of productive livestock or of a pet.
11. Use of a compound of formula I according to any one of claims 1 to 5 in the preparation of an ectoparasiticidal composition for domestic animals, productive livestock or pets.
12. A combination preparation for controlling parasites in or in or on warm-blooded animals, which comprises, in addition to a compound of formula I according to claim 1 , at least one further active ingredient having the same direction of action or having a different direction of action and at least one physiologically tolerable carrier.
PCT/EP2000/011471 1999-11-19 2000-11-17 Organic compounds WO2001036367A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU25068/01A AU2506801A (en) 1999-11-19 2000-11-17 Organic compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2116/99 1999-11-19
CH211699 1999-11-19

Publications (2)

Publication Number Publication Date
WO2001036367A2 true WO2001036367A2 (en) 2001-05-25
WO2001036367A3 WO2001036367A3 (en) 2001-11-08

Family

ID=4226258

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/011471 WO2001036367A2 (en) 1999-11-19 2000-11-17 Organic compounds

Country Status (2)

Country Link
AU (1) AU2506801A (en)
WO (1) WO2001036367A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941966A1 (en) * 1989-12-15 1991-06-20 Schering Ag HALOGENED OLEFINS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PEST CONTROL
TR26865A (en) * 1992-06-30 1994-08-19 Ciba Geigy Ag W-halovinilalkankarboxylic acid derivatives and pesticides containing them.

Also Published As

Publication number Publication date
WO2001036367A3 (en) 2001-11-08
AU2506801A (en) 2001-05-30

Similar Documents

Publication Publication Date Title
AU762529B2 (en) Pesticides
RU2259370C2 (en) Aminoheterocyclamide derivatives eliciting pesticide activity
US6620767B1 (en) Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
AU2005219559B2 (en) Use of pyrimidine compounds in the preparation of parasiticides
US6667326B1 (en) Pesticidal aminoheterocyclamide compounds
WO2001036367A2 (en) Organic compounds
WO2001036371A1 (en) Carbonic acid derivatives and their use as ectoparasiticidal composition
WO2001036372A1 (en) Organic compounds and their use in the control of ectoparasites
US20020173473A1 (en) Organic compounds
ZA200103747B (en) Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)